Evidence map›Paper›PMID 42750788›Full record

ArticleNeuro-oncology practice2026

A multidisciplinary program for meningioma treatment, research, and support services.

Zora Arum, Ramin A Morshed, Brooke C Braman, Kanish Mirchia, Javier E Villanueva-Meyer, Vaughn Mouton, Tracy Ward, Charlotte Huie, Jennifer Viner, Alon Witztum and 29 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Zora ArumDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Ramin A MorshedDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0001-8464-6041
Brooke C BramanDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Kanish MirchiaDepartment of Pathology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-7371-7059
Javier E Villanueva-MeyerDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-5910-0757
Vaughn MoutonDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Tracy WardDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Charlotte HuieDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Jennifer VinerDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Alon WitztumDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0009-0005-0231-1050
Molly Rose MorrisseyDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Ashley BazellDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Stephanie LewisDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Linda PhamDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Sasha MortezaeiDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Melike PekmezciDepartment of Pathology, University of California San Francisco, San Francisco, CA, USA.
Jacob S YoungDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-5499-4325
Lauren BoretaDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-7286-9253
Matthew S SuskoDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Jean L NakamuraDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Steve E BraunsteinDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-9841-9357
Marc H LevinDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
Shawn L Hervey-JumperDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Tarun AroraDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Manish K AghiDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Tina R JimenezDivision of Neuro-Psychology, University of California San Francisco, San Francisco, CA, USA.
Christina Weyer-JamoraDivision of Neuro-Psychology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-7729-0320
Arie PerryDepartment of Pathology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-8300-7261
Penny K SneedDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
John F de GrootDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Edward F ChangDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Naomi HofferDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Susan M ChangDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0009-0001-2084-3959
Mitchel S BergerDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Michael W McdermottDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0001-7944-5181
Philip V TheodosopoulosDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
William C ChenDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Nancy Ann Oberheim BushDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
David R RaleighDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0001-9299-8864

Funding

Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of GliomaP01CA118816 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Susan M Chang, Janine Marie Lupo · 2007 to 2026
$44.7M
Project 3: Understanding genomic and social and structural drivers of response-predictive inflammatory states underlying health disparities in patients with breast cancerU54CA302452 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Shawn L. Hervey-Jumper · 2025 to 2026
$7.3M
Understanding druggable drivers of meningioma tumorigenesisR01CA262311 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RALEIGH, DAVID R · 2021 to 2025
$2.7M
Mechanistic and Functional Genomic Interrogation of Meningioma Radiotherapy Response GenesR21NS141756 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David R Raleigh · 2025 to 2026
$451k
Chromosomal instability and radiation sensitivity in meningiomaK99CA296996 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI William C Chen · 2025 to 2026
$326k
NCI NIH HHS K99 CA296996NCI NIH HHS P01 CA118816NCI NIH HHS P50 CA097257NCI NIH HHS R01 CA262311NCI NIH HHS U54 CA302452NINDS NIH HHS R21 NS141756
6 · The paper itself

Abstract

Background: Standard treatments for meningioma include surgery and radiotherapy, but the timing and technical details of these treatments are debated, particularly as advances in meningioma biology expand options for treatment. Patients with meningioma may experience adverse quality-of-life and neurocognitive sequelae following diagnosis and treatment, and survivorship resources for these patients are limited. Methods: We initiated a Multidisciplinary Meningioma Program (MMP) to advance the care of patients at our institution in September 2024. The MMP consists of synergistic clinical, scientific, and survivorship resources, including a weekly tumor board and multidisciplinary clinic, clinical trials and prospective registries for translational research, a meningioma-specific support group, and basic and translational research. In this article, we describe the implementation and initial patient-facing aspects of the MMP. Results: In the first 15 months of the MMP, 602 cases were discussed at the MMP tumor board, and 142 patients were seen in consultation in the MMP multidisciplinary clinic. Twelve percent of patients discussed in the MMP tumor board were offered clinical trial enrollment, and 84% were offered prospective registry enrollment. Participants in the MMP support group cited informational and emotional benefits. Following implementation of the MMP, the clinical volume of consultations for meningioma increased by 87.0%-533.3%, and the volume of treatments increased by 42.1%-115.2% across clinical departments. Conclusions: Through creation of a multidisciplinary program for meningioma treatment, research, and support services, we enabled consensus clinical recommendations, streamlined enrollment on clinical trials and prospective registries, improved access to support services, and increased patient volume.

Indexed as

meningiomamultidisciplinary carequality improvementquality of life

Identifiers

PMID42750788
PMCPMC13578502

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.